SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (924)5/23/2005 7:04:16 PM
From: John Metcalf  Read Replies (3) | Respond to of 3722
 
Hello, Bernard, Ray, Jon, others.

NRGN -- While I was fiddling around with my day job, Neurogen did a sharp up move in six weeks (30%) and sharp down (11% today). On the fundamental level, investors may have been looking for something that didn't happen. Capturing half of each move would have been good money.

I'm attracted to this short-term opportunity because I wouldn't mind being "trapped" long. The MRK Vanilloid receptor program is exciting.



To: Jibacoa who wrote (924)7/13/2005 1:19:46 PM
From: Jibacoa  Respond to of 3722
 
CBTE Has continued on the uptrend that started on July 1 from the 4.35 level. In spite of its loss in the Dec.Q and the 1st Q in March, the insiders had bought some in November and April and it seems to be forming a"saucer" pattern on its daily chart.<g>

bigcharts.marketwatch.com

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News